Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-30622619

RESUMEN

Aster glehni (AG) has been used in cooking and as a medicine to treat various diseases for over hundreds of years in Korea. To speculate the protective effects of AG on skin barrier, we estimated the protein levels of biomarkers related to skin barrier protection in human keratinocytes, HaCaT cells treated with sodium dodecyl sulfate (SDS), or 2,4-dinitrochlorobenzene (DNCB). The protein levels for keratin, involucrin, defensin, tumor necrosis factor alpha (TNFα), peroxisome proliferator-activated receptor delta (PPARδ), 5' adenosine monophosphate-activated protein kinase (AMPK), serine palmitoyltransferase long chain base subunit 2 (SPTLC2), and transient receptor potential cation channel subfamily V member 4 (TRPV4) were evaluated using western blotting or immunocytochemistry in HaCaT cells. AG extract increased the protein levels of PPARδ, phosphorylated AMPK, SPTLC2, keratin, involucrin, and defensin compared to the SDS or DNCB control group. However, TNFα expression increased by SDS or DNCB was decreased with AG extract. The order of action of each regulatory biomarker in AG pathway was identified TRPV4→PPARδ→AMPK from antagonist and siRNA treatment studies. AG can ameliorate the injury of keratinocytes caused by SDS or DNCB through the sequential regulation of TRPV4→PPARδ→AMPK pathway.

2.
Bioorg Med Chem ; 23(15): 4970-4979, 2015 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-26068017

RESUMEN

Reactive oxygen species have been implicated in several diseases, particularly in ischemia-reperfusion injury. Quercetin 3-O-methyl ether has been reported to show potent antioxidant and neuroprotective activity against neuronal damage induced by reactive oxygen species. Several aminoethyl-substituted derivatives of quercetin 3-O-methyl ether have been synthesized to increase water solubility while retaining antioxidant and neuroprotective activity. Among such derivatives, compound 3a shows potent and well-balanced antioxidant activity in three types of cell-free assay systems and has in vivo neuroprotective effects on transient focal ischemic injury induced by the occlusion of the middle cerebral artery in rats.


Asunto(s)
Antioxidantes/síntesis química , Fármacos Neuroprotectores/síntesis química , Quercetina/análogos & derivados , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Encéfalo/metabolismo , Encéfalo/patología , Modelos Animales de Enfermedad , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Peroxidación de Lípido/efectos de los fármacos , Masculino , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Quercetina/química , Quercetina/farmacología , Quercetina/uso terapéutico , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Relación Estructura-Actividad
3.
Phytochemistry ; 101: 83-90, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24582277

RESUMEN

An ethyl acetate fraction of the aerial parts of Caryopteris incana (Verbenaceae) showed potent cytoprotective effects against damage to HepG2 cells induced by tert-butylhydroperoxide (t-BHP). To search for hepatoprotective components of C. incana, various chromatographic separations of the ethyl acetate soluble fraction of C. incana led to isolation of three phenylpropanoid glycosides, 6‴-O-feruloylincanoside D, 6‴-O-sinapoylincanoside D and caryopteroside, and two iridoid glycosides, incanides A and B, together with 17 known compounds. Structures of these compounds were determined by spectroscopic analyses. The absolute stereochemistry of the caryopteroside was established with the help of circular dichroism data and in comparison with literature data. All isolated substances were determined for their cytoprotective effects against t-BHP-induced toxicity in HepG2 cells. Among the tested compounds, 6'-O-caffeoylacteoside exhibited the most potent cytoprotective activity with an IC50 value of 0.8±0.1 µM against t-BHP-induced toxicity. Structure-activity relationships of the assay results indicated an important role of the catechol moiety in phenylpropanoid, iridoid and flavonoid derivatives in eliciting cytoprotective effects.


Asunto(s)
Extractos Vegetales/química , Sustancias Protectoras/química , Verbenaceae/química , Citoprotección , Células Hep G2 , Humanos , Concentración 50 Inhibidora , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Estructura Molecular , Componentes Aéreos de las Plantas/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Sustancias Protectoras/aislamiento & purificación , Sustancias Protectoras/farmacología , Estereoisomerismo , Relación Estructura-Actividad , terc-Butilhidroperóxido/toxicidad
4.
Arch Pharm Res ; 36(11): 1385-91, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23640382

RESUMEN

N,N-dimethylamphetamine (DMA), a methamphetamine (MA) analog, is known as a weak central nervous system stimulant. As DMA possesses a chiral center, we investigated the enantioselective formation of N,N-dimethylamphetamine N-oxide (DMANO) and MA from DMA using human liver microsomes, recombinant cytochrome P450 (CYP) 2D6, and flavin monooxygenases (FMO) 1 and 3. d-DMA was preferentially metabolized to MA, whereas l-DMA was more rapidly transformed to DMANO in human liver microsomes. CYP2D6 showed a preference for catalyzing N-demethylation of d-DMA, and the intrinsic clearance (Clint) ratio of d-isomer to l-isomer was 1.41. FMO1 catalyzed the formation of slightly less d-DMANO than l-DMANO, and the Clint ratio of the D- to L-isomer was 0.78. The reverse was observed for the formation of DMANO by FMO3. However, given the minor contribution of FMO3 compared with FMO1, it would not affect the overall enantioselective formation of DMANO in human liver microsomes. Enantioselectivities in the formation of MA and DMANO in human liver microsomes were consistent with those of CYP2D6 and FMO1, respectively.


Asunto(s)
Citocromo P-450 CYP2D6/metabolismo , Metanfetamina/análogos & derivados , Oxigenasas/metabolismo , Animales , Humanos , Masculino , Metanfetamina/metabolismo , Metilación , Microsomas Hepáticos/enzimología , Oxidación-Reducción , Ratas , Estereoisomerismo
5.
Anal Bioanal Chem ; 401(4): 1353-63, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21744239

RESUMEN

A sensitive and rapid method based on liquid chromatography-triple-quadrupole tandem mass spectrometry (LC-MS/MS) with electrospray ionization (ESI) has been developed and validated for the screening and confirmation of 44 exogenous anabolic steroids (29 parent steroids and 15 metabolites) in human urine. The method involves an enzymatic hydrolysis, liquid-liquid extraction, and detection by LC-MS/MS. A triple-quadrupole mass spectrometer was operated in positive ESI mode with selected reaction monitoring (SRM) mode for the screening and product ion scan mode for the confirmation. The protonated molecular ions were used as precursor ions for the SRM analysis and product ion scan. The intraday and interday precisions of the target analytes at concentrations of the minimum required performance levels for the screening were 2-14% and 2-15%, respectively. The limits of detection for the screening and confirmation method were 0.1-10 ng/mL and 0.2-10 ng/mL, respectively, for 44 steroids. This method was successfully applied to analysis of urine samples from suspected anabolic steroid abusers.


Asunto(s)
Anabolizantes/orina , Cromatografía Liquida , Espectrometría de Masa por Ionización de Electrospray , Esteroides/orina , Urinálisis/métodos , Urinálisis/normas , Humanos , Límite de Detección , Estructura Molecular , Factores de Tiempo
6.
Arch Pharm Res ; 34(6): 1023-34, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21725824

RESUMEN

Ischemic preconditioning can provide protection to neurons from subsequent lethal ischemia. The molecular mechanisms of neuronal ischemic tolerance, however, are still not well-known. The present study, therefore, examined the role of MAPK and PI3K/Akt pathways in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation (OGD) in cultured rat cortical neurons. Ischemic tolerance was simulated by preconditioning of the neurons with sublethal 1-h OGD imposed 12 h before lethal 3-h OGD. The time-course studies of relative phosphorylation and expression levels of ERK1/2, JNK and p38 MAPK showed lack of their involvement in ischemic tolerance. However, there were significant increases in Akt phosphorylation levels during the reperfusion period following preconditioned lethal OGD. In addition, Bcl-2 associated death promoter (Bad) and GSK-3ß were also found to be inactivated during that reperfusion period. Finally, treatment with an inhibitor of PI3K, wortmannin, applied from 15 min before and during lethal OGD abolished not only the preconditioning-induced neuroprotection but also the Akt activation. Concomitant with blockade of the Akt activation, PI3K inhibition also resulted in activation of Bad and GSK-3ß. The results suggest that ischemic tolerance induced by sublethal OGD preconditioning is primarily mediated through activation of the PI3K/Akt pathway, but not the MAPK pathway, in rat cortical neurons.


Asunto(s)
Isquemia Encefálica/metabolismo , Precondicionamiento Isquémico/métodos , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Androstadienos/farmacología , Animales , Corteza Cerebral/metabolismo , Glucosa/deficiencia , Neuronas/metabolismo , Oxígeno/metabolismo , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación , Inhibidores de Proteínas Quinasas/farmacología , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Wortmanina
7.
Rapid Commun Mass Spectrom ; 25(16): 2261-7, 2011 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-21755547

RESUMEN

A simple and accurate liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for the quantitative determination of ephedrine, pseudoephedrine, methylephedrine, cathine, salbutamol, morphine and epitestosterone in human urine. Urine samples were spiked with internal standard and diluted with acetonitrile. After centrifugation, the supernatants were directly analyzed by LC/MS/MS using the selected reaction monitoring (SRM) mode. The linearity, intra- and inter-day precision, accuracy, limit of detection (LOD) and limit of quantification (LOQ) were evaluated and the method was found to be accurate and reproducible for the quantitation of threshold substances. When the method was applied to the analysis of blind urine samples for the proficiency test, the results were close to the nominal concentrations, within 87.7-106.6% of nominal values, suggesting that the developed methods can be successfully applied to routine doping analyses.


Asunto(s)
Cromatografía Liquida/métodos , Doping en los Deportes , Propanolaminas/orina , Espectrometría de Masas en Tándem/métodos , Albuterol/orina , Epitestosterona/orina , Humanos , Morfina/orina , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
8.
Bioorg Med Chem Lett ; 21(10): 2850-4, 2011 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-21504847

RESUMEN

The excessive calpain activation causes serious cellular damage or even cell death in neurological disorders such as stroke and Alzheimer's disease. Oxidative stress has also been implicated in the initiation or progression of neurodegenerative diseases. In the present studies, a series of cinnamoyl ketoamides 4a-4j were synthesized as hybrid structures of antioxidants and calpain inhibitors. Cinnamoyl ketoamides, possessing an alkyl chain at the α-position, showed potent µ-calpain inhibitory activities indicating that the cinnamoyl skeleton can be regarded as an acyclic variant of calpain inhibitory chromone carboxamide 2. Among synthesized, compound 4e was the most potent inhibitor of µ-calpain (IC(50)=0.13 µM) and also exhibited strong antioxidant activities in DPPH and superoxide anion radical scavenging and lipid peroxidation inhibition assay systems.


Asunto(s)
Amidas/síntesis química , Amidas/farmacología , Antioxidantes/síntesis química , Antioxidantes/farmacología , Activación Enzimática/efectos de los fármacos , Glicoproteínas/síntesis química , Glicoproteínas/farmacología , Amidas/química , Antioxidantes/química , Sitios de Unión , Cinamatos/síntesis química , Cinamatos/química , Cinamatos/farmacología , Cristalografía por Rayos X , Glicoproteínas/química , Concentración 50 Inhibidora , Cetonas/síntesis química , Cetonas/química , Cetonas/farmacología , Modelos Moleculares , Estructura Molecular
9.
Eur J Med Chem ; 46(5): 1721-8, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21397369

RESUMEN

The overactivation of µ-calpain can cause serious cell damage in several diseases. Furthermore, cell death in a number of neurodegenerative disorders is linked to the overproduction of reactive oxygen species. Therefore, antioxidants and µ-calpain inhibitors could have the therapeutic potentials to treat cell death related diseases. New chromone carboxamide derivatives 3 were synthesized to provide alternative µ-calpain inhibitors to compound 2, a conformationally constrained structural variant of MDL 28,170. Compounds 3h and 3l exhibited the most potent µ-calpain inhibitory activities (IC50=0.09-0.10 µM), and were comparable to 2 in this respect (IC50=0.07 µM). Compound 3i showed both potent µ-calpain inhibitory activity (IC50=0.28 µM) and antioxidant activities in DPPH scavenging and lipid peroxidation inhibition assays.


Asunto(s)
Antioxidantes/farmacología , Calpaína/antagonistas & inhibidores , Cromonas/farmacología , Antioxidantes/síntesis química , Antioxidantes/química , Calpaína/metabolismo , Cromonas/síntesis química , Cromonas/química , Peroxidación de Lípido/efectos de los fármacos , Estructura Molecular , Estereoisomerismo , Relación Estructura-Actividad
10.
J Forensic Sci ; 56(4): 1044-8, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21418218

RESUMEN

5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a designer hallucinogen derived from tryptamine and is reportedly abused and involved in criminal activities. For the detection of 5-MeO-DIPT use, a liquid chromatography-tandem mass spectrometric method for 5-MeO-DIPT and its metabolites, 5-hydroxy-N,N-diisopropyltryptamine (5-OH-DIPT) and 5-methoxy-N,N-isopropyltryptamine (5-MeO-IPT) was developed and validated in rat urine. The urine samples were pretreated by protein precipitation with acetonitrile and introduced into a BDS HYPERSIL C(18) column (50 × 2.0 mm, 5 µm) for chromatographic separation. Mobile phases consisted of methanol, water, and 1% formic acid, and gradient elution was used at a flow rate of 0.2 mL/min. For the MS detection, multiple-reaction monitoring analysis was adopted. The linear range was 0.01-10 µg/mL, and the lower limit of quantification was 10 ng/mL for all analytes. The intra- and interday accuracies and precisions met the criteria (<15%). The developed method was successfully applied to the drug-treated rat urine.


Asunto(s)
5-Metoxitriptamina/análogos & derivados , Alucinógenos/orina , 5-Metoxitriptamina/química , 5-Metoxitriptamina/orina , Animales , Cromatografía Liquida , Drogas de Diseño/química , Toxicología Forense , Alucinógenos/química , Ratas , Serotonina/análogos & derivados , Serotonina/química , Serotonina/orina , Espectrometría de Masa por Ionización de Electrospray
11.
Biol Pharm Bull ; 33(12): 2024-8, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21139245

RESUMEN

The 5-HT6 receptor (5-HT6R) is a member of the class of recently discovered 5-hydroxytryptamine (5-HT) receptors. Due to the lack of selective 5-HT6R ligands, the cellular signaling mechanisms of the 5-HT6R are poorly understood. We previously developed a cell-based high-throughput screening (HTS) method for the 5-HT6R and screened synthetic chemical compounds. In the present study, we expanded our screening into natural products to find novel 5-HT6R ligands. We found that the ethyl acetate fraction from the root of Caragana sinica (537-18BE) produced the most potent antagonistic activity. After further isolation of 537-18BE, we found that three stilbene derivatives, (+)-α-viniferin, miyabenol C and pallidol, are active constituents of 537-18BE inhibiting the 5-HT6R. Among them, (+)-α-viniferin showed the most potent inhibition, and miyabenol C also produced a considerable inhibition. When examined effects on other neurotransmitters for selectivity, 537-18BE and three stilbene derivatives did not produce any notable effects on 5-HT4, 5-HT7, or muscarinic acetylcholine M1 (M(1)) receptors. Furthermore, 5-HT6R antagonistic effects of (+)-α-viniferin, miyabenol C and pallidol were confirmed on extracellular signal-regulated kinase 1 and 2 (ERK1/2) which exerts effects in downstream pathways of 5-HT6R activation.


Asunto(s)
Caragana/química , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Extractos Vegetales/farmacología , Antagonistas de la Serotonina/farmacología , Serotonina/metabolismo , Estilbenos/farmacología , Células HEK293 , Células HeLa , Humanos , Extractos Vegetales/química , Raíces de Plantas , Compuestos Policíclicos/farmacología , Estilbenos/química , Estilbenos/aislamiento & purificación
12.
Rapid Commun Mass Spectrom ; 24(21): 3139-45, 2010 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-20941760

RESUMEN

Amphetamine (AP) and amphetamine-type stimulants, methamphetamine (MA) and N,N-dimethylamphetamine (DMA), are known as central nervous system stimulants, and their abuse throughout the world has recently increased. Since it is difficult to physically distinguish among AP, MA and DMA, analysts may not be aware of what abusers have administered. In this study, following the detection of specific metabolites of AP, MA and DMA as biomarkers in abuser urines, a rapid and sensitive method was developed for the identification and classification of AP-type stimulants abusers. After the simple filtration of the urine samples, the samples were directly analyzed using a liquid chromatography/tandem mass spectrometry system with selected reaction monitoring (SRM)-triggered quantitation-enhanced data-dependent MS/MS (QED-MS/MS) for the simultaneous qualitative and quantitative analysis of p-hydroxy AP, p-hydroxy MA, p-hydroxy DMA, AP, MA, DMA and DMA N-oxide. The determination of p-hydroxy AP, p-hydroxy MA, AP, MA, DMA and DMA N-oxide was accurate and reproducible, with the limits of quantitation of 5 ng/mL in urine. When applied to the urine samples of suspected AP-type stimulants abusers, the abused drugs were precisely identified between MA and DMA abusers.


Asunto(s)
Anfetaminas/clasificación , Cromatografía Liquida/métodos , Espectrometría de Masas en Tándem/métodos , Anfetaminas/química , Anfetaminas/metabolismo , Anfetaminas/orina , Animales , Consumidores de Drogas , Humanos , Análisis de los Mínimos Cuadrados , Masculino , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
13.
Prog Neuropsychopharmacol Biol Psychiatry ; 34(6): 1011-7, 2010 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-20493231

RESUMEN

Opuntia ficus-indica var. saboten Makino (Cactaceae) is used to treat burns, edema, dyspepsia, and asthma in traditional medicine. The present study investigated the beneficial effects of the n-butanolic extract of O. ficus-indica var. saboten (BOF) on memory performance in mice and attempts to uncover the mechanisms underlying its action. Memory performance was assessed with the passive avoidance task, and western blotting and immunohistochemistry were used to measure changes in protein expression and cell survival. After the oral administration of BOF for 7 days, the latency time in the passive avoidance task was significantly increased relative to vehicle-treated controls (P<0.05). Western blotting revealed that the expression levels of brain-derived neurotrophic factor (BDNF), phosphorylated cAMP response element binding-protein (pCREB), and phosphorylated extracellular signal-regulated kinase (pERK) 1/2 were significantly increased in hippocampal tissue after 7 days of BOF administration (P<0.05). Doublecortin and 5-bromo-2-deoxyuridine immunostaining also revealed that BOF significantly enhanced the survival of immature neurons, but did not affect neuronal cell proliferation in the subgranular zone of the hippocampal dentate gyrus. These results suggest that the subchronic administration of BOF enhances long-term memory, and that this effect is partially mediated by ERK-CREB-BDNF signaling and the survival of immature neurons.


Asunto(s)
Reacción de Prevención/efectos de los fármacos , Hipocampo/efectos de los fármacos , Memoria/efectos de los fármacos , Opuntia , Extractos Vegetales/farmacología , Tallos de la Planta , Animales , Western Blotting , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Hipocampo/metabolismo , Inmunohistoquímica , Masculino , Ratones , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Neurogénesis/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fosforilación/efectos de los fármacos , Transducción de Señal/efectos de los fármacos
14.
Chem Pharm Bull (Tokyo) ; 58(2): 238-41, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20118587

RESUMEN

To search for secondary metabolites of Alnus hirsuta (Betulaceae), various chromatographic separations of the ethyl acetate soluble fraction of the stem bark of A. hirsuta led to the isolation of a new diarylheptanoid glycoside, (3R)-1,7-bis-(4-dihydroxyphenyl)-3-heptanol 3-O-beta-D-glucopyranosyl(1-->3)-beta-D-xylopyranoside (13) and twelve diarylheptanoid derivatives, namely, oregonin (1), rubranoside A (2), hirsutanonol 5-O-beta-D-glucopyranoside (3), rubranoside B (4), rubranoside C (5), hirsutanonol (6), hirsutenone (7), (5S)-O-methylhirsutanonol (8), platyphylloside (9), platyphyllonol 5-O-beta-D-xylopyranoside (10), aceroside VII (11) and platyphyllenone (12). Isolates were assessed for their hepatoprotective effects against tert-butylhydroperoxide (t-BHP)-induced toxicity in HepG2 cells. Of these isolates, compounds 1-8 showed significant hepatoprotective effects on t-BHP-induced damage to HepG2 cells, with 8 exhibiting the greatest protective effect (50.7 + or - 3.7% at a concentration of 10 microM).


Asunto(s)
Alnus/química , Citoprotección , Diarilheptanoides/análisis , Diarilheptanoides/farmacología , Glicósidos/análisis , Glicósidos/farmacología , Hepatocitos/efectos de los fármacos , Alnus/metabolismo , Supervivencia Celular/efectos de los fármacos , Diarilheptanoides/aislamiento & purificación , Glicósidos/aislamiento & purificación , Células Hep G2 , Hepatocitos/citología , Humanos , Estructura Molecular , Corteza de la Planta/química , terc-Butilhidroperóxido/efectos adversos
15.
Biol Pharm Bull ; 33(1): 11-7, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20045928

RESUMEN

The complex molecular cascades of ischemic tolerance in brain cells remain unclear. Recently, sphingolipid-related metabolite ceramide has been implicated as a second messenger in many biological functions, including neuronal survival and death. The present study, therefore, examined the roles of ceramide (Cer) in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation (OGD) using primary cultured cortical neurons of rats. Preconditioning of the neurons with sublethal 1-h OGD produced robust neuroprotection against cell death induced by lethal 3-h OGD imposed 12 h after preconditioning when measured by the MTT assay. Analysis of sphingolipids using LC-MS/MS showed that the ischemic preconditioning resulted in significant increases in the levels of C(16 : 0) Cer, C(18 : 0) Cer, C(20 : 0) Cer, C(24 : 0) Cer, C(24 : 1) Cer and the total ceramide contents compared with the sham-washed control group. However, sphingomyelin contents were not significantly changed by the ischemic preconditioning, suggesting that ceramides were increased through the de novo synthetic pathway. In the case of severe OGD paradigm, levels of ceramide and sphingomyelin in the lethal OGD group were not significantly different from those of the control group or the lethal OGD group with preconditioning at any time points studied. Treatment with an inhibitor of de novo ceramide synthesis, fumonisin B(1), during the ischemic preconditioning period completely blocked preconditioning-induced ischemic tolerance. Moreover, application of a non-cytotoxic concentration of exogenous cell-permeable ceramide produced neuroprotection against lethal OGD. The results suggest that ceramides increased by sublethal OGD preconditioning play an important role in induction of ischemic tolerance.


Asunto(s)
Isquemia Encefálica/metabolismo , Ceramidas/metabolismo , Corteza Cerebral/fisiología , Glucosa/deficiencia , Hipoxia , Precondicionamiento Isquémico , Neuronas/fisiología , Animales , Isquemia Encefálica/tratamiento farmacológico , Carcinógenos Ambientales , Células Cultivadas , Ceramidas/uso terapéutico , Corteza Cerebral/citología , Fumonisinas/farmacología , Vaina de Mielina/metabolismo , Fármacos Neuroprotectores/uso terapéutico , Ratas , Ratas Sprague-Dawley , Esfingolípidos/metabolismo
16.
J Biol Chem ; 285(13): 10016-10029, 2010 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-20093369

RESUMEN

The 5-HT(6) receptor (5-HT(6)R) is one of the most recently cloned serotonin receptors, and it plays important roles in Alzheimer disease, depression, and learning and memory disorders. However, unlike the other serotonin receptors, the cellular mechanisms of 5-HT(6)R are poorly elucidated relative to its significance in human brain diseases. Here, using a yeast two-hybrid assay, we found that the human 5-HT(6)R interacts with Jun activation domain-binding protein-1 (Jab1). We also confirmed a physical interaction between 5-HT(6)R and Jab1 using glutathione S-transferase pulldown, fluorescence resonance energy transfer, co-immunoprecipitation, and immunocyto(histo)chemistry assays. The manipulation of Jab1 expression using Jab1 small interference RNA decreased 5-HT(6)R-mediated activity and cell membrane expression of 5-HT(6)R, whereas overexpression of Jab1 produced no significant effect. In addition, we demonstrated that the activation of 5-HT(6)R induced the translocation of Jab1 into the nucleus and increased c-Jun phosphorylation and the interaction between Jab1 and c-Jun. Furthermore, we found that 5-HT(6)R and Jab1 were up-regulated in middle cerebral artery occlusion-induced focal cerebral ischemic rats and in cultured cells exposed to hypoxic insults, suggesting possible protective roles for 5-HT(6)R and Jab1. These findings suggest that Jab1 provides a novel signal transduction pathway for 5-HT(6)R and may play an important role in 5-HT(6)R-mediated behavior changes in the brain.


Asunto(s)
Regulación de la Expresión Génica , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Péptido Hidrolasas/metabolismo , Receptores Acoplados a Proteínas G/química , Receptores de Serotonina/química , Animales , Encéfalo/metabolismo , Encefalopatías/metabolismo , Células CHO , Complejo del Señalosoma COP9 , Membrana Celular/metabolismo , Supervivencia Celular , Cricetinae , Cricetulus , Humanos , Isquemia/patología , ARN Interferente Pequeño/metabolismo , Ratas , Ratas Sprague-Dawley
17.
Planta Med ; 76(7): 701-4, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-19960413

RESUMEN

Deoxypodophyllotoxin (DPT) is a bioactive compound of Anthriscus sylvestris (Apiaceae). In the present study, the inhibition of cytochrome P450 (CYP) by DPT was evaluated in human liver microsomes (HLM) and the baculovirus-insect cell-expressed human CYPs using a cocktail probe assay. When a mixture of specific CYP substrates was incubated with DPT in HLM, CYP2C9-catalyzed diclofenac 4-hydroxylation and CYP3A4-catalyzed midazolam 1-hydroxylation were strongly inhibited by DPT, with IC (50) values of 6.3 and 9.2 microM, respectively. The Lineweaver-Burke plots for the inhibition of CYP2C9 and CYP3A4 in HLM and baculovirus-insect cell-expressed human CYPs were consistent with a competitive type of inhibition. From these results, DPT was characterized to be a competitive inhibitor of CYP2C9 and CYP3A4, with K(i) values of 3.5 and 10.8 microM in HLM and 24.9 and 3.5 microM in baculovirus-insect cell-expressed human CYPs, respectively.


Asunto(s)
Apiaceae , Hidrocarburo de Aril Hidroxilasas/antagonistas & inhibidores , Inhibidores del Citocromo P-450 CYP3A , Podofilotoxina/análogos & derivados , Citocromo P-450 CYP2C9 , Citocromo P-450 CYP3A , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos , Humanos , Microsomas Hepáticos , Podofilotoxina/farmacología
18.
J Pharmacol Sci ; 111(2): 110-6, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19834282

RESUMEN

In the present study, we assessed the effects of gluco-obtusifolin, isolated from the seeds of Cassia obtusifolia L., and its aglycone, obtusifolin, on the learning and memory impairments induced by scopolamine using the passive avoidance and the Morris water maze tasks in mice. Gluco-obtusifolin (1, 2, and 4 mg/kg, p.o.) and obtusifolin (0.25, 0.5, 1, and 2 mg/kg, p.o.) significantly reversed scopolamine-induced cognitive impairments in the passive avoidance test (P<0.05). Moreover, gluco-obtusifolin (2 mg/kg, p.o.) and obtusifolin (0.5 mg/kg, p.o.) improved escape latencies, swimming times in the target quadrant, and crossing numbers in the zone where the platform previously existed in the Morris water maze test. In the acetylcholinesterase assay, gluco-obtusifolin and obtusifolin were found to inhibit acetylcholinesterase activity in vitro (IC(50) = 37.2 and 18.5 microM, respectively) and ex vivo. These results suggest that gluco-obtusifolin and its aglycone may be useful for the treatment of cognitive impairment, and that its beneficial effects are mediated, in part, by the enhancement of cholinergic signaling.


Asunto(s)
Antraquinonas/farmacología , Antraquinonas/uso terapéutico , Glucósidos/farmacología , Glucósidos/uso terapéutico , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/tratamiento farmacológico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Escopolamina/toxicidad , Animales , Antraquinonas/química , Reacción de Prevención/efectos de los fármacos , Cassia/química , Inhibidores de la Colinesterasa/farmacología , Relación Dosis-Respuesta a Droga , Glucósidos/química , Concentración 50 Inhibidora , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Ratones Endogámicos ICR , Estructura Molecular , Extractos Vegetales/química , Semillas/química , Natación
19.
Bioorg Med Chem Lett ; 19(21): 6009-13, 2009 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-19796942

RESUMEN

Due to high reactivity, reactive oxygen species can attack biological molecules leading to cell or tissue injury. In this study, glucose moiety was attached at the C-7 position of quercetin 3-O-methyl ether (1) and luteolin (2) through glycosidic bond or ether linkage. The glucose-containing compounds showed potent DPPH and superoxide anion radical scavenging and lipid peroxidation inhibition activities and nearly equivalent protective actions to the parent aglycons against the H2O2-induced oxidative neuronal damage in primary cultured rat cortical cells. Among the compounds tested, 3b and 3c were the most potent (IC50 values=7.33 and 5.34 microM, respectively), exhibiting nearly equivalent actions to the parent compounds 1 and 2 (IC50=3.50 and 3.75 microM, respectively).


Asunto(s)
Flavonas/síntesis química , Depuradores de Radicales Libres/síntesis química , Glucósidos/síntesis química , Luteolina/síntesis química , Fármacos Neuroprotectores/síntesis química , Quercetina/análogos & derivados , Animales , Células Cultivadas , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Flavonas/química , Flavonas/farmacología , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Glucósidos/química , Glucósidos/farmacología , Peróxido de Hidrógeno/metabolismo , Peroxidación de Lípido , Luteolina/química , Luteolina/farmacología , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/farmacología , Quercetina/síntesis química , Quercetina/química , Quercetina/farmacología , Ratas , Especies Reactivas de Oxígeno/metabolismo , Xantina Oxidasa/antagonistas & inhibidores , Xantina Oxidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...